Replimune

0 followers


Replimune is pioneering a new generation of cancer treatments called oncolytic immunotherapies.

Industries

Employees

51-200

Links

Org chart

Philip Astley-Sparke
CEO & Chairman

Philip Astley-Sparke

Collapse
Robert Coffin
Founder, President and Chief Research & Development Officer
Colin Love
Chief Operating Officer
Pamela Esposito
Chief Business Officer
Chris Sarchi
Chief Commercial Officer
Kostas Xynos
Chief Medical Officer
Tanya Lewis
Chief Development Operations Officer
Emily Hill
Chief Operating Officer